Exploring the Chemical Diversity of Qurs-E-Ziabetus Sada: A Stride Towards Analytical and Biological Validation
Awadhesh Kumar1,3, Akash Ved2
, Irfan Aziz1
, Syed Misbahul Hasan1
, Pushpendra Soni1
and Shom Prakash Kushwaha1*
1Faculty of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, Uttar Pradesh, India.
2Faculty of Pharmacy, Dr. APJ Abdul Kalam Technical University, Sector 11, Jankipuram Vistar, Lucknow, India.
3Goel Institute of Pharmaceutical Sciences, Faizabad Road, Lucknow, India.
Corresponding Author E-mail: shompk@iul.ac.in
Article Received on : 21 Oct 2024
Article Accepted on :
Article Published : 10 Mar 2025
Reviewed by: Dr. Eswar munnangi
Second Review by: Dr. Pooja Saini
Final Approval by: Dr. Pounraj Thanasekaran
Qurs-E-Ziabetus Sada, a renowned traditional Unani formulation, has been extensively used for managing diabetes mellitus. This paper delves into the chemical diversity of its bioactive constituents and explores their potential roles in modulating key signaling pathways such as PI3K-Akt, AMPK, and MAPK, which are pivotal in glucose metabolism and insulin sensitivity. The formulation's hypoglycemic effects are attributed to the synergistic action of its herbal and mineral components. However, the absence of comprehensive chemical profiling and biological validation limits its integration into evidence-based medicine. This study underscores the necessity of rigorous analytical validation, employing advanced techniques and well-designed trials to confirm the formulation's chemical complexity and therapeutic efficacy. Furthermore, the paper advocates for standardization protocols to ensure the safety, efficacy, and reproducibility of Unani formulations, highlighting their potential for global acceptance and integration into modern healthcare systems.
KEYWORDS:Chemical diversity; Diabetes mellitus; herbal formulation; Hyphenateted mass spectrometry; Iron oxide; Qurs-E-Ziabetus Sada; Thymoquinone; Unani
Download this article as:
Copy the following to cite this article: Kumar A, Ved A, Aziz I, Hasan S. M, Soni P, Kushwaha S. P. Exploring the Chemical Diversity of Qurs-E-Ziabetus Sada: A Stride Towards Analytical and Biological Validation. Orient J Chem 2025;41(2). |
Copy the following to cite this URL: Kumar A, Ved A, Aziz I, Hasan S. M, Soni P, Kushwaha S. P. Exploring the Chemical Diversity of Qurs-E-Ziabetus Sada: A Stride Towards Analytical and Biological Validation. Orient J Chem 2025;41(2). Available from: https://bit.ly/4idEaEZ |
Introduction
Diabetes mellitus has long been treated with Qurs-E-Ziabetus Sada, a traditional Unani medication. It is a traditional herbal formulation commonly used for managing diabetes, particularly in regions where traditional medicine is a prevalent part of healthcare. Herbal remedies like Qurs-E-Ziabetus Sada are valued for their perceived efficacy in controlling blood sugar levels and supporting overall diabetic health. It combines mineral and floral elements to create a vast chemical variety that may have therapeutic uses. However, its incorporation into contemporary medicine has been impeded by the absence of thorough chemical profiling and biological confirmation. To comprehend the formulation’s pharmacological activities and guarantee its safety and effectiveness, it is essential to investigate its chemical diversity. This work intends to close the gap between conventional wisdom and contemporary scientific confirmation by utilising sophisticated analytical methods such as hyphenated mass spectrometry, opening the door for standardisation and international recognition of this age-old cure.
South Asia, particularly India, is experiencing a significant increase in diabetes prevalence. The region is home to over 72 million adults with diabetes, expected to exceed 123 million by 2035 1. The integration of Unani medicine into national health programs, such as the NPCDCS-AYUSH project in India, has shown promising results in screening and managing non-communicable diseases (NCDs) 2. The World Health Organization recognized Unani medicine which offers promising formulations for managing diabetes mellitus, a leading global health concern.
Qurs-E-Ziabetus-Sada
As per National Formulary of Unani Medicine, Part VI, published by Government of India, Ministry of AYUSH Qurs-E-Ziabetus-Sada contains ingredients known for their hypoglycemic properties, helping to regulate blood sugar levels. The formulation is composed of various herbal ingredients believed to improve insulin sensitivity and regulate glucose metabolism, making it popular in regions where traditional medicine is prevalent. The manufacturing process involves cleaning, grinding and sieving these herbs (Table 1), followed by mixing and tablet formation with a binding agent. The tablets are then dried and packaged under controlled conditions to ensure product stability and efficacy3. According to most commonly cited sources in scholarly texts in various national and international research papers Qurs-E- Ziabetus Sada is composed of several herbs, each of these herbs contains bioactive compounds that contribute to its anti-diabetic effects. We have considered the constituents from these sources for the purpose of this review.
Table 1: Active Components in Qurs-E-Ziabetus Sada
S.No: | Unani name | Botanical name | Active Constituents |
1. | Tukhm-e-Khurfa | Portulaca oleracea | Oleraceins,Kaempferol,
α-linolenic acid, Polysaccharides. |
The aqueous extract of Portulaca oleracea also prevents diabetic vascular inflammation, hyperglycemia, and diabetic endothelial dysfunction in type II diabetic db/db mice.4 | |||
2. | Tukhm-e-Kahu | Lactuca sativa | Lactucaxanthin, Chlorogenic acid, Dietary Fiber |
Lactucaxanthin from lettuce inhibits α-amylase and α-glucosidase activities, reducing post-prandial hyperglycemia in diabetic rats.5 | |||
3. | Rubb-us-Soos | Glycyrrhiza glabra | PolysaccharidesAmorfrutins
Isoliquiritigenin |
Licorice and its metabolites show significant therapeutic potential for treating diabetes mellitus. These compounds enhance insulin sensitivity, improve glucose utilization, reduce oxidative stress, and target multiple signaling pathways like PI3K/Akt, AMPK, NF-κB, and AGE-RAGE.6 | |||
4. | Tabasheer | Bambusa arundinacea | SilicaFlavonoids
phenolic acids |
Bambusa arundinacea-mediated ZnO nanoparticles exhibit significant anti-hyperglycemic, antimicrobial, and anticancer activities, highlighting their pharmaceutical potential.7 | |||
5. | Gil-e-Armani | Bole Armeniac | Iron oxide |
Burah Armani Bole’s potential as an effective anti-diabetic agent in Unani medicine, showcasing its pharmacological properties and benefits for managing diabetes-related complications.8 | |||
6. | Gul-e-Surkh | Rosa damascena | Anthocyaninscitronellol
flavonoids |
The methanol extract of Rosa damascena flowers effectively inhibits α-glucosidase activity and postprandial hyperglycemia in normal and diabetic rats, suggesting potential anti-diabetic applications.9 | |||
7. | Kishnsez Khusk | Coriandrum sativum | Fatty AcidsPolyphenols
Vitamin C |
The methanol extract of Rosa damascena flowers inhibits α-glucosidase and reduces postprandial hyperglycemia, demonstrating potential for managing diabetes by controlling carbohydrate absorption.10 | |||
8. | Aquaqia | Acacia Arabica | LeucineFlavonoids
Alkaloids |
Acacia arabica bark extract improves insulin secretion and glucose metabolism, reduces DPP-IV enzyme activity, and enhances GLP-1 levels, supporting its antidiabetic potential.11 | |||
9. | Samgh-e-Arabi | Acacia Senegal | PolysaccharidesGlycoproteins
Uronic acids |
Gum acacia significantly improves glucose tolerance and reduces insulin levels in healthy individuals, indicating its potential role in managing postprandial blood sugar and insulin responses.12 | |||
10. | Sandal Safaid | Santalum album | SantaleneSantyl acetate |
Santalum album effectively improves the lipid profile in diabetic rats.13 | |||
11. | Sandal Surkh | Pterocarpus santalinus | PterocarpolPterosupin
Kaempferol |
Santalinus has many flavonoids and polyphenols that exert their anti-diabetic effects via anti-inflammatory and antioxidant pathways.14 | |||
12. | Gulnar | Punica granatum | CyanidinGallic Acid |
Positive effects in ameliorating blood glucose homeostasis. 15 | |||
13. | Kafoor | Cinnamomum camphora | CinnamaldehydeSafranal
Borneol |
Camphora leaves may have potential beneficial effects for the treatment of diabetes mellitus.16 |
Qurs-E-Ziabetus Sada exhibits a enormous chemical diversity (Figure 1). Thymoquinone, has been shown to enhance insulin sensitivity and reduce oxidative stress in diabetic models. It acts through the activation of the peroxisome proliferator activated receptor gamma pathway, which plays a crucial role in glucose metabolism 17. The alkaloid trigonelline has demonstrated insulinotropic effects, enhancing insulin secretion from pancreatic cells 18. Cinnamaldehyde improves insulin sensitivity by increasing glucose uptake in peripheral tissues and enhancing the activity of insulin receptor kinase 19. Charantin, polypeptide-P, and vicine exhibit hypoglycemic effects by mimicking insulin activity and promoting glucose uptake in skeletal muscle and adipose tissue. It also upregulates GLUT4 (Glucose Transporter Type 4) expression, facilitating glucose transport into cells 20.
The active components of Qurs-E-Ziabetus Sada modulate several key signaling pathways, including the PI3K-Akt, AMPK, and MAPK pathways. These pathways are crucial for maintaining glucose homeostasis, enhancing insulin sensitivity and mitigating cellular stress responses. The modulation of these pathways by the herbal constituents of Qurs-E-Ziabetus Sada underpins its therapeutic efficacy in managing diabetes and its associated complications and may be used to the development of enhanced therapeutic benefits21-24.
![]() |
Figure 1: Chemical diversity in Qurs-E-Ziabetus Sada |
Discussion
Chemical and scientific validation of Unani treatments may elevate their status within global healthcare systems. Moreover, there is a pressing need for rigorous research. High-quality, well-designed studies are essential to ensure the chemical validation, safety, efficacy and reproducibility of Unani treatments. Such research will provide the necessary evidence to validate traditional uses of these formulations, thereby increasing their acceptance and integration into mainstream healthcare. Exploration of Active Components interactions maybe executed conducting a detailed phytochemical analysis of these components, understanding their chemical structures and biological interactions.
Conclusion
The integration of Unani treatments like Qurs-E-Ziabetus Sada into global healthcare systems requires robust chemical and scientific validation. Rigorous, high-quality research is essential to establish their safety, efficacy, and reproducibility. Conducting well-designed studies and comprehensive phytochemical analyses can unveil the active components, elucidate their chemical structures, and map their biological interactions. Such efforts will provide the scientific evidence needed to validate traditional uses, fostering trust and acceptance among the global medical community. By bridging traditional wisdom with modern analytical approaches, this research paves the way for the standardization and integration of Unani formulations into evidence-based healthcare systems.
Acknowledgement
Awadhesh Kumar is a Ph.D. Research Scholar at Faculty of Pharmacy, Integral University, Lucknow. Irfan Aziz and Shom Prakash Kushwaha humbly acknowledge Integral University Lucknow for the Seed Money Grant for Research (Project Sanction No: IUL/ICEIR/SMP/2024/0017, Manuscript communication number: IU/R&D/2024- MCN0003195).
References
- Ramachandran, A.; Snehalatha, C.; Ma, R. Diabetes Res Clin Pract 2014, 103 (2), 231–237.
CrossRef - Heidari, A. Ethnobiol Ethnomed 2017, 4, 1-10.
- Government of India, M. of A. National Formulary of Unani Medicine, (CCRUM):2021 86-87.
- Lee, A. S.; Lee, Y. J.; Lee, S. M.; Yoon, J. J.; Kim, J. S.; Kang, D. G.; Lee, H. S. Evid Based Complementary Altern Med. 2012 (1), 741824.
- Gopal, S. S.; Lakshmi, M. J.; Sharavana, G.; Sathaiah, G.; Sreerama, Y. N.; Baskaran, V. Food Funct. 2017, 8 (3), 1124–1131.
CrossRef - Yang, L.; Jiang, Y.; Zhang, Z.; Hou, J.; Tian, S.; Liu, Y. Ethnopharmacol. 2020, 263, 113216.
CrossRef - Jayarambabu, N.; Venkatappa Rao, T.; Rakesh Kumar, R.; Akshaykranth, A.; Shanker, K.; Suresh, V. Materials Today Communications 2021, 26, 101688.
CrossRef - Sheema, D.; Jamal, M. International Research Journal of Modernization in Engineering Technology and Science 2024, 5, 2582–5208.
- Gholamhoseinian, A.; Fallah, H.; Sharifi far, F. J Phytomedicine 2009, 16 (10), 935–941.
CrossRef - Chithra, V.; Leelamma, S. Food Chemistry 1999, 67 (3), 229–231.
CrossRef - Ansari, P.; Islam, S. S.; Akther, S.; Khan, J. T.; Shihab, J. A.; Abdel-Wahab, Y. H. A. Bioscience Reports 2023, 43 (5), BSR20230329.
CrossRef - Sharma, R. D. Nutrition Research 1985, 5 (12), 1437–1441.
CrossRef - Kulkarni, C. R.; Joglekar, M. M.; Patil, S. B.; Arvindekar, A. U. J. Pharmaceutical Biology 2012, 50 (3), 360–365.
CrossRef - El-Badawy, R. E.; Ibrahim, K. A.; Hassan, N. S.; El-Sayed, W. M. J. Iranian Journal of Basic Medical Sciences 2019, 22 (8), 932–939.
- Gharib, E.; Montasser, S. Iran Pharm Res 2019, 18 (1), 358–368.
- Jiang, X.; Zhang, X.-H.; Li, Y.-X.; Chen, K.; Lin, B.; Lu, T.-Q.; Yang, M.; Chen, G.-T.; Fan, B.-Y.; Wang, W.-L. J. Phytochemistry Letters 2023, 57, 101–105.
CrossRef - Shaukat, A. Frontiers in Nutrition 2023, 10.
CrossRef - Haxhiraj, M.; White, K.; Terry, A. J International Journal of Molecular Sciences 2024, 25 (13).
CrossRef
- Eqbal, K. J. Journal of Complementary and Integrative Medicine 18, 147–153.
CrossRef - Prabhakar, D. P.; Doble, M. Chinese Journal of Integrative Medicine 2011, 17, 563–574.
CrossRef - Goswami, K.; Singh, A.; Kumar, R.; Sharma, P.; Gupta, S. J Curr. Diabetes Rev. 2024, 20(2), 92–102.
- Noor,; Akhtar, J.; Singh, B.; Ahmad, M.; Khan, M.I. J. Phytotherapy Research 2023, 37.11, 5058-5079.
CrossRef - Zia, N.; Khan, S.; Rizwan, U.; Shahid, M. J Authorea Preprints 2023.
- Ajmal, M.; Ahmad, M.; Alam, M.A.; Akhtar, J. J Authorea Preprints 2023.
This work is licensed under a Creative Commons Attribution 4.0 International License.